Efecto perjudicial de la pandemia por SARS-CoV-2 en la sintomatología digestiva en pacientes con síndrome de intestino irritable

Detrimental impact of SARS-CoV-2 pandemic in the symptomatology of patients with irritable bowel syndrome Irritable Bowel Syndrome (IBS) is a more frequent disorder in the brain-gut axis interaction in the world.COVID-19 has affected the population's mental health, and its impact on clinical severity in patients with IBS is unknown.Objective: To evaluate the effect of psychosocial stress produced by the pandemic on the severity of gastrointestinal symptoms.Methodology: 54 women and three men with IBS were interviewed by telephone.Factors associated with quality of life, comorbidities, IBS subtype, and COVID-19 diagnosis were asked.Calls were developed between June 2020 to January 2021.Results: 75% had Diarrheal IBS (IBS-D), 67% had comorbidities, 47% with busy work, and 70% in person, five patients (9%) were diagnosed with COVID-19.Of the total, 88% referred to change in gastrointestinal symptoms, 56% increased abdominal pain, and 95% bloating.Abdominal pain was negatively associated with quality of life (p < 0.036), and the incomplete evacuation's sensation positively with difficulty sleeping (p < 0.034).Conclusion: In this study, IBS patients interviewed by telephone reported higher abdominal pain and subjective bloating associated with the pandemic by SARS-CoV-2.